TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients - Concepedia

Concepedia

Publication | Open Access

TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients

DOI Full Paper Access

22

Citations

16

References

2012

Year

Christian Körner, Katarina Riesner, Benjamin Krämer, Marianne Eisenhardt, A Glässner, F Wolter, Thomas Berg, Tobias Müller, Tilman Sauerbruch, Jacob Nattermann,

Abstract

The increased prevalence of patients with a 626C allele and the homozygous 683AA genotype in HCV-infected patients with HCC suggests that these genetic variants are a risk factor for HCC in chronic hepatitis C.

References

	Year	Citations

Page 1